Sunovion Pharmaceuticals reported positive late-stage test results for a new drug as both an add-on and standalone treatment for seizures associated with epilepsy.
Sunovion Pharmaceuticals reported positive late-stage test results for a new drug as both an add-on and standalone treatment for seizures associated with epilepsy.
